½ÃÀ庸°í¼­
»óǰÄÚµå
1618273

¼¼°èÀÇ ÄÚ ½ºÇø°Æ® ½ÃÀå : ÀλçÀÌÆ®, °æÀï ȯ°æ ¹× ½ÃÀå ¿¹Ãø(2030³â)

Nasal Splints - Market Insights, Competitive Landscape, and Market Forecast - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DelveInsight | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼°è ÄÚ ½ºÇø°Æ® ½ÃÀå ±Ô¸ð´Â 2023³â 22¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È 3.44%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 26¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÄÚ ½ºÇø°Æ® ½ÃÀåÀº ÄÚ ¼ö¼úÀÇ À¯º´·ü Áõ°¡, ÄÚ ¿Ü»ó ¹ß»ý·ü Áõ°¡, ¹Ì¿ë ½Ã¼ú¿¡ ´ëÇÑ Àνİú ¼ö¿ä Áõ°¡ µî º¹ÇÕÀûÀÎ ¿äÀÎÀ¸·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ °áÇÕµÇ¾î ¼ö¿ä ¹× °ø±ÞÀ» ¸ðµÎ ÃËÁøÇÏ´Â °ß°íÇÑ ½ÃÀå ȯ°æÀ» Çü¼ºÇÏ¿© 2024³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ÄÚ ½ºÇø°Æ® »ê¾÷ÀÇ °ý¸ñÇÒ¸¸ÇÑ ¼ºÀåÀ» À̲ø °ÍÀÔ´Ï´Ù.

¿µ±¹¹Ì¿ë¼ºÇü¿Ü°úÀÇ»çÇùȸ(British Association of Aesthetic Plastic Surgeons-UK)°¡ Á¦°øÇÑ Ãֽе¥ÀÌÅÍ(2023³â)¿¡ µû¸£¸é, ³²¼ºÀº Àüü ¼ºÇü¼ö¼úÀÇ 7%¸¦ Â÷ÁöÇØ 2021³â ´ëºñ 118% Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¶ÇÇÑ ¿©¼ºÀº Àüü ¼ºÇü¼ö¼úÀÇ 93%¸¦ Â÷ÁöÇØ 2021³â ´ëºñ 101% Áõ°¡ÇßÀ¸¸ç, ±× Áß ÄÚ ¼ºÇü¼úÀÌ °¡Àå Àαâ ÀÖ´Â ¼ö¼ú·Î 72% Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

¶ÇÇÑ ±¹Á¦¹Ì¿ë¼ºÇü¿Ü°úÇÐȸ(2024³â)ÀÇ ÃÖ±Ù µ¥ÀÌÅÍ¿Í Åë°è¿¡ µû¸£¸é, 2023³â Àü ¼¼°èÀûÀ¸·Î ¾à 1,100¸¸ °ÇÀÇ ÄÚ ¼ºÇü ¼ö¼úÀÌ ½ÃÇàµÇ¾î 21.6% Áõ°¡ÇßÀ¸¸ç, ÀÌ Áß 65.8%°¡ 18-34¼¼ ¿¬·É´ëÀÇ °³Àο¡°Ô ½ÃÇàµÇ¾ú½À´Ï´Ù.

ÀÌ·¯ÇÑ ÄÚ ¼ö¼ú Áõ°¡´Â ¼ö¼ú ÈÄ °ü¸® ¹× ȸº¹ °úÁ¤¿¡¼­ ÄÚ ½ºÇø°Æ®ÀÇ Áß¿äÇÑ ¿ªÇÒ·Î ÀÎÇØ ÄÚ ½ºÇø°Æ® ½ÃÀåÀ» Á÷Á¢ÀûÀ¸·Î ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ºñÁß°Ý ¼ºÇü¼ú, ÄÚ ¼ºÇü¼ú, ÄÚ»À °ñÀý ¼ö¸® µîÀÇ ½Ã¼ú ÈÄ ÄÚ ½ºÇø°Æ®Àº ÄÚÀÇ ³»ºÎ ¶Ç´Â ¿ÜºÎ ±¸Á¶¸¦ ¾ÈÁ¤È­ÇÏ¿© ÄÚ°¡ ¿øÇÏ´Â ¸ð¾ç°ú ¹èÄ¡·Î ¿Ã¹Ù¸£°Ô Ä¡À¯µÇµµ·Ï º¸ÀåÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÀÌ ºÎ¸ñÀº ºñ°­ ºØ±«¸¦ ¹æÁöÇÏ°í ºÎÁ¾À» ÃÖ¼ÒÈ­Çϸç ÈäÅÍ Á¶Á÷ Çü¼ºÀÇ À§ÇèÀ» ÁÙÀ̰í Áß¿äÇÑ Ä¡À¯ ´Ü°è¿¡¼­ ¼¶¼¼ÇÑ Á¶Á÷ÀÌ ¼Õ»óµÇÁö ¾Êµµ·Ï º¸È£ÇÕ´Ï´Ù. ÄÚ ¸·ÈûÀÇ À¯º´·ü Áõ°¡, ¹Ì¿ë ½Ã¼úÀÇ Àαâ Áõ°¡, ¼ö¼ú ±â¼ú Çâ»ó µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ÄÚ ¼ö¼ú °Ç¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÄÚ ½ºÇø°Æ®°ú °°Àº È¿°úÀûÀÎ ¼ö¼ú ÈÄ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© Àü ¼¼°è Àüü ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è ÄÚ ½ºÇø°Æ® ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² À¯Çüº°, ¿ëµµº°, Åõ¿© °æ·Îº°, ÃÖÁ¾»ç¿ëÀÚº° µ¿Çâ, °æÀï ±¸µµ, ±¹°¡º° µ¿Çâ µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÄÚ ½ºÇø°Æ® ½ÃÀå º¸°í¼­ ¼­·Ð

Á¦2Àå ÄÚ ½ºÇø°Æ® ½ÃÀå ÁÖ¿ä ¿ä¾à

Á¦3Àå °æÀï ±¸µµ

Á¦4Àå ±ÔÁ¦ ºÐ¼®

  • ¹Ì±¹
  • À¯·´
  • ÀϺ»
  • Áß±¹

Á¦5Àå ÄÚ ½ºÇø°Æ® ½ÃÀåÀÇ ÁÖ¿ä ¿äÀÎ ºÐ¼®

  • ÄÚ ½ºÇø°Æ® ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ÄÚ ½ºÇø°Æ® ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
  • ÄÚ ½ºÇø°Æ® ½ÃÀå ±âȸ

Á¦6Àå ÄÚ ½ºÇø°Æ® ½ÃÀå : PorterÀÇ Five Forces ºÐ¼®

Á¦7Àå ÄÚ ½ºÇø°Æ® ½ÃÀå Æò°¡

  • À¯Çüº°
  • ¿ëµµº°
  • Åõ¿© °æ·Îº°
  • ÃÖÁ¾»ç¿ëÀÚº°
  • Áö¿ªº°

Á¦8Àå ÄÚ ½ºÇø°Æ® ½ÃÀå ±â¾÷°ú Á¦Ç° °³¿ä

  • Boston Medical Products Inc.
  • Summit Medical LLC
  • Olympus
  • Smith+Nephew PLC
  • DTR Medical Ltd.
  • Network Medical Products Ltd.
  • Surgiform Technologies LLC
  • Medtronic PLC
  • Hemostasis, LLC
  • Anthony Products, Inc.
  • Traumec Health Technology
  • Audio Technologies SRL
  • Websinger Ges.m.b.H.
  • Stryker Corporation
  • SPIGGLE & THEIS Medizintechnik GmbH
  • EON Meditech Pvt. Ltd.

Á¦9Àå KOL(Key Opinion Leader)ÀÇ °ßÇØ

Á¦10Àå ÇÁ·ÎÁ§Æ® Á¢±Ù

Á¦11Àå DelveInsight¿¡ ´ëÇØ

Á¦12Àå ¸éÃ¥»çÇ×°ú ¹®ÀÇ

LSH 25.01.03

Nasal Splints Market By Type (Malleable Nasal Splints, Airway Nasal Splints, and Bivalve Nasal Splints), Application (Plastic Surgery, Ent-Surgery, and Others), Route of Administration (Intranasal and Extra Nasal), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of nasal surgeries, increasing incidence of nasal trauma, and rising awareness and demand for aesthetic procedures across the globe.

The global nasal splints market was valued at USD 2.20 Billion in 2023, growing at a CAGR of 3.44% during the forecast period from 2024 to 2030, to reach USD 2.69 Billion by 2030. The market for nasal splints has witnessed significant growth driven by a combination of factors including the rising prevalence of nasal surgeries, increasing incidence of nasal trauma, and growing awareness and demand for aesthetic procedures. Together, these factors create a robust market environment, driving both demand and supply, and leading to significant growth in the nasal splints industry during the forecast period from 2024 to 2030.

Nasal Splints Market Dynamics:

According to the latest data provided by the British Association of Aesthetic Plastic Surgeons-UK (2023), men accounted for 7% of all cosmetic surgery procedures, reflecting a 118% increase from 2021, with rhinoplasty being the most popular procedure among them, showing a 45% rise. Additionally, women accounted for 93% of all cosmetic surgery procedures, reflecting 101% increase from 2021, with rhinoplasty being the most popular procedure among them, showing a 72% rise.

Additionally, as per the recent data and stats provided by International Society of Aesthetic Plastic Surgery (2024), in 2023, globally, approximately 1.1 million procedures of rhinoplasty was conducted, a 21.6% increase, with 65.8% of these surgeries being performed on individuals aged 18-34.

Thus, the increase in nasal surgeries directly boosts the market for nasal splints due to the critical role these devices play in the postoperative care and recovery process. After procedures such as septoplasty, rhinoplasty, or nasal fracture repair, nasal splints are used to stabilize the internal or external nasal structures, ensuring that the nose heals correctly in the desired shape and alignment. These splints prevent the nasal passages from collapsing, minimize swelling, reduce the risk of scar tissue formation, and protect the delicate tissues from injury during the critical healing phase. As the number of nasal surgeries rises driven by factors such as a higher prevalence of nasal obstructions, the growing popularity of cosmetic procedures, and improvements in surgical techniques, the demand for effective postoperative solutions like nasal splints increases thereby boosting the overall market across the globe.

Additionally, an increase in strategic activities are also anticipated to augment the nasal splints market growth. For instance, In January 2022, Stryker, a U.S.-based multinational medical technology company, launched the Rinastent bioresorbable nasal splint for use in nasal surgeries. It prevents movement of the septal flap and minimizes complications after septoplasty.

However, difficulty in breathing, discomfort, pain, and risk of infection and the presence of alternative methods such as nasal packing, nasal stents, nasal tampons, and others may hinder the future market of nasal splints.

Nasal Splints Market Segment Analysis:

Nasal Splints Market by Type (Malleable Nasal Splints, Airway Nasal Splints, and Bivalve Nasal Splints), Application (Plastic Surgery, Ent-Surgery, and Others), Route of Administration (Intranasal and Extra Nasal), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of nasal splints market the airway nasal splints are expected to hold a significant share in 2023. The increasing adoption of airway nasal splints is significantly enhancing the overall airway splints market, driven by their role in improving nasal airflow and post-surgical recovery outcomes. These devices are widely used to prevent nasal airway collapse after procedures such as rhinoplasty or septoplasty, ensuring that patients experience optimal healing and improved breathing. The splints reduce inflammation, stabilize nasal structures, and promote effective drainage, making them indispensable for post-operative care.

Technological advancements, such as biocompatible materials and customizable designs, have further improved patient comfort, minimized irritation, and reduced complications, boosting their acceptance among surgeons and patients. Moreover, the rising awareness of airway-related disorders such as sleep apnea, chronic nasal congestion, and obstructive respiratory conditions has increased the demand for preventive and corrective interventions where airway nasal splints play a pivotal role.

Thus, according to the aforementioned factors the airway nasal splint category will have the highest revenue share, which will eventually boost the overall airway splints market, during the forecast period.

North America is expected to dominate the overall nasal splints market:

North America is expected to account for the highest proportion of the nasal splints market in 2023, out of all regions. This can be ascribed to the increasing incidence of nasal surgeries and increasing incidence of nasal trauma. Additionally, growing awareness and demand for cosmetic procedures coupled with increased awareness programs for nasal disorders, and the presence of key market players engaged in strategic activities across the region are expected to escalate the market of nasal splints during the forecast period.

According to the most recent estimates provided by the American Society of Plastic Surgeons, in 2023, in the United States, approximately 47,307 nose reshaping (rhinoplasty) were performed and 44,503 rhinoplasty performed in 2022.

Thus, the rising incidence of rhinoplasty procedures is significantly boosting the overall market for nasal splints due to the increased demand for post-surgical support and stabilization. Rhinoplasty, a cosmetic surgery aimed at altering the shape and function of the nose, often requires the use of nasal splints to ensure optimal healing and to maintain the new shape of the nasal structures. As the popularity of rhinoplasty grows, driven by increasing cosmetic and reconstructive surgery trends, so does the need for effective post-operative care solutions. Nasal splints play a critical role in this recovery process by providing internal support that minimizes nasal movement, reduces the risk of complications such as septal deformities or adhesions, and promotes proper alignment of the nasal tissues. Their role in preventing post-surgical bleeding, minimizing swelling, and enhancing overall patient outcomes makes them an essential component of rhinoplasty recovery. This surge in demand for nasal splints, driven by the growing number of rhinoplasty surgeries, is consequently propelling market growth across the region.

Additionally, as per the data published in a recent study (2022), in the U.S nasal bone fractures were reported as the most frequent facial fractures, comprising 40-50% of cases, primarily due to physical assaults, falls, sports injuries, and traffic accidents. In the U.S., about 50,000 individuals annually experienced nasal fractures, representing 40% of bone injuries, with males twice as likely to be affected as females. Most injuries involved the cartilaginous lower two-thirds of the nose. These statistics highlight a growing need for nasal splints, as they play a critical role in stabilizing nasal structures post-injury, driving demand and boosting their market growth across the region.

Therefore, the above-mentioned factors are expected to bolster the growth of the nasal splints market in North America during the forecast period.

Nasal Splints Market Key Players:

Some of the key market players operating in the nasal splints market include Boston Medical Products Inc., Summit Medical LLC, Olympus, Smith+Nephew PLC, DTR Medical Ltd., Network Medical Products Ltd., Surgiform Technologies LLC, Medtronic PLC, Hemostasis, LLC, Anthony Products, Inc., Traumec Health Technology, Audio Technologies SRL, Websinger Ges.m.b.H., Stryker Corporation, SPIGGLE & THEIS Medizintechnik GmbH, EON Meditech Pvt. Ltd., and others.

Recent Developmental Activities in the Nasal Splints Market:

  • In May 2021, Summit Medical, and Innovia Medical Company launched the U.S. Accudent Nasal Splints for stabilizing nasal septal cartilage.
  • In November 2020, Thyssen'sche Handelsgesellschaft mbH (THG) acquired a majority stake in SPIGGLE & THEIS Medizintechnik GmbH. The business of SPIGGLE & THEIS is related to the development, production, and distribution of medical products for the ENT segment. Since SPIGGLE & THEIS has a strong international footprint, these kinds of acquisitions help the Nasal Splints market to grow.

Key Takeaways From the Nasal Splints Market Report Study:

  • Market size analysis for current nasal splints size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the nasal splints market.
  • Various opportunities available for the other competitors in the nasal splints market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current nasal splints market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for nasal splints market growth in the coming future?

Target Audience who can be Benefited from This Nasal Splints Market Report Study:

  • Nasal splints product providers
  • Research organizations and consulting companies
  • Nasal splints -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in nasal splints
  • Various end-users who want to know more about the nasal splints market and the latest technological developments in the nasal splints market.

Frequently Asked Questions for the Nasal Splints Market:

1. What are nasal splints?

  • Nasal Splints are devices that are used majorly after nasal surgeries to prevent nasal bone movement from their position to minimize any problems inside the nose, such as inflammation, nose bleeding. These devices are also used in providing structural support to the nose in maintaining the shape after reconstructive surgery.

2. What is the market for nasal splints?

  • The global nasal splints market was valued at USD 2.20 Billion in 2023, growing at a CAGR of 3.44% during the forecast period from 2024 to 2030, to reach USD 2.69 Billion by 2030.

3. What are the drivers for the nasal splints market?

  • The market for nasal splints has witnessed significant growth driven by a combination of factors including the rising prevalence of nasal surgeries, increasing incidence of nasal trauma, growing awareness and demand for aesthetic procedures, and enhanced product development activities by key market players worldwide. Together, these factors create a robust market environment, driving both demand and supply, and leading to significant growth in the nasal splints industry during the forecast period from 2024 to 2030.

4. Who are the key players operating in the nasal splints market?

  • Some of the key market players operating in the Nasal Splints market include Boston Medical Products Inc., Summit Medical LLC, Olympus, Smith+Nephew PLC, DTR Medical Ltd., Network Medical Products Ltd., Surgiform Technologies LLC, Medtronic PLC, Hemostasis, LLC, Anthony Products, Inc., Traumec Health Technology, Audio Technologies SRL, Websinger Ges.m.b.H., Stryker Corporation, SPIGGLE & THEIS Medizintechnik GmbH, EON Meditech Pvt. Ltd., and others.

5. Which region has the highest share in the nasal splints market?

  • North America is expected to account for the highest proportion of the nasal splints market in 2023, out of all regions. This can be ascribed to the increasing prevalence of nasal surgeries, increasing incidence of nasal trauma, rising awareness, increase government initiatives coupled with increased awareness programs for nasal disorders, and the presence of key market players engaged in strategic activities across the region are expected to escalate the market of nasal splints during the forecast period.

Table of Contents

1. Nasal Splints Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Nasal Splints Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Nasal Splints Market Key Factors Analysis

  • 5.1. Nasal Splints Market Drivers
    • 5.1.1. Rising prevalence of nasal surgeries
    • 5.1.2. Increasing incidence of nasal trauma
    • 5.1.3. Rising awareness and demand for aesthetic procedures
  • 5.2. Nasal Splints Market Restraints and Challenges
    • 5.2.1. Difficulty in breathing, discomfort, pain, and risk of infection
    • 5.2.2. Presence of alternative methods such as nasal packing, nasal stents, nasal tampons, and others
  • 5.3. Nasal Splints Market Opportunities
    • 5.3.1. Integration of nasal splints with features to improve airflow in sleep apnea patients

6. Nasal Splints Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Nasal Splints Market Assessment

  • 7.1. By Type
    • 7.1.1. Malleable Nasal Splints
    • 7.1.2. Airway Nasal Splints
    • 7.1.3. Bivalve Nasal Splints
  • 7.2. By Application
    • 7.2.1. Plastic Surgery
    • 7.2.2. ENT-Surgery
    • 7.2.3. Others
  • 7.3. By Route of Administration
    • 7.3.1. Intranasal
    • 7.3.2. Extra Nasal
  • 7.4. By End User
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.1.2. Canada Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.1.3. Mexico Nasal Splints Market Size in USD Million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.2.2. Germany Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.2.3. United Kingdom Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.2.4. Italy Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.2.5. Spain Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.2.6. Rest of Europe Nasal Splints Market Size in USD Million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.3.2. Japan Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.3.3. India Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.3.4. Australia Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.3.5. South Korea Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Nasal Splints Market Size in USD Million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.4.2. Africa Nasal Splints Market Size in USD Million (2021-2030)
      • 7.5.4.3. South America Nasal Splints Market Size in USD Million (2021-2030)

8. Nasal Splints Market Company and Product Profiles

  • 8.1. Boston Medical Products Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Summit Medical LLC
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Olympus
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Smith+Nephew PLC
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. DTR Medical Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Network Medical Products Ltd.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Surgiform Technologies LLC
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Medtronic PLC
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Hemostasis, LLC
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Anthony Products, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Traumec Health Technology
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Audio Technologies SRL
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Websinger Ges.m.b.H.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Stryker Corporation
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. SPIGGLE & THEIS Medizintechnik GmbH
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. EON Meditech Pvt. Ltd.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦